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mice, but not in AF-1 and neither in AF-2 mice, although these later still presented a 
moderate uterine hypertrophy essentially due to stromal edema. 
We conclude that ERαAF-1 is involved in the E2-induced proliferative response 
in vivo, whereas it is dispensable for vasculoprotective E2 effects. We thus propose 
that preferential ERαAF-2 activation with a minimal ERαAF-1 action would optimize 
ERα modulation in hormone therapy of menopause.
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Background: Based on both experimental and clinical data, tamoxifen has been 
proposed to have cardiovascular benefi ts, although the mechanism(s) contributing to 
that protective effect are still poorly understood. In vitro experiments demonstrated 
that tamoxifen elicits transcriptional effect through Estrogen Receptor (ER) α, but 
other targets can participate to its actions. However, whereas tamoxifen selectively 
activates the activating function (AF)-1 of ERα, we recently showed that this ERα 
sub-function is dispensable for the atheroprotective action of 17beta-estradiol (E2), 
the main ligand of ERs. The goal of the present work is to determine to which extent 
ERα and its AF-1 mediate the vasculoprotective action of tamoxifen.
Methodology and Results: 1) Our data confi rm that tamoxifen exerts an athero-
protective action on LDL-r-/- female mice but, in contrast to E2, it fails to accelerate 
reendothelialization after carotid electric injury. 2) Tamoxifen and E2 elicit differences 
in gene expression profi les in the mouse aorta. 3) Finally, the atheroprotective action of 
tamoxifen is abrogated in ERα-/-LDL-r-/- mice as well as in LDL-r-/- mice selectively 
defi cient in ERαAF-1 (ERαAF-10/0LDL-r-/-).
Conclusions: Our results demonstrate for the fi rst time that tamoxifen mediates 
its actions in vivo through the selective activation of ERαAF-1, which is suffi cient to 
prevent atheroma, but not to accelerate endothelial healing. 
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Objective: To analyse whether plasmatic levels of leukocytes derived microparticles 
(LMP) predict unstable plaques in patients with high grade carotid stenosis. 
Background: Preventive carotid surgery in asymptomatic patients is currently 
debated given the improvement of medical therapy. Therefore non invasive biomarkers 
that can predict unstable plaque are needed. LMP originating from activated or apoptotic 
leukocytes are the major subset in human carotid extracts. 
Method: Forty two patients with greater than 70% carotid stenosis were enrolled. 
Using a new standardized high-sensitivity fl ow cytometry assay, LMP were measured 
before thromboendarterectomy. The removed plaques were characterized as stable 
or unstable using histological analysis according to AHA criteria. LMP levels were 
analyzed according to the plaque morphology.
Results: The median LMP levels were signifi cantly higher in patients with unstable 
plaques (n=28, CD11b66b+MP/μl 240 [147-394] and CD15+MP/μl 147 [60-335]) 
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The “semicarbazide sensitive amine oxidase” (SSAO) transforms primary 
amines into aldehydes, ammonia and hydrogen peroxide and is widely expressed by 
vascular smooth muscle cells (VS MC). SSAO expression is increased during VS MC 
differentiation like in others cell types. Disregulation of VS MC phenotype participates 
to the development of atherosclerosis lesion. To evaluate if the absence of SSAO could 
participate to the development of atherosclerosis, the laboratory established a double 
ApoE/SSAO knock out mice model (ApoE-/-SSAO-/-).
25 week-old ApoE-/-SSAO-/- mice presented a signifi cant 50% increase in plaque 
surface associated with an 80% decrease in α-actin expression in the media of aortic 
sinus from ApoE-/-SSAO-/- mice compared to ApoE-/- mice. We noticed a small T-cell 
infi ltration in the media from ApoE-/-SSAO-/- mice. ApoE-/-SSAO-/- and ApoE-/- mice 
were transferred with labelled CD45.1 peripheral bone marrow cells from wild type 
mice. 5 day after PBMC injection, the number of labeled CD45.1 cells was increased 
in aorta, decreased in blood and unchanged in spleen from ApoE-/-SSAO-/- mice 
compared to ApoE-/- mice. 
In conclusion, the absence of the SSAO increases the atherosclerosis in 
ApoE-/- mice. This result could be explained by a switch of VS MC to an 
inflammatory phenotype. 
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Estrogens infl uence most of the physiological processes in mammals, including 
but not limited to reproduction, cognition, behavior, vascular system, metabolism and 
bone integrity and estrogen infl uence the pathophysiology of numerous diseases. These 
actions are mediated by the activation of estrogen receptors (ER) alpha (ERα), which 
regulates target gene transcription through two independent activation functions (AF) 
-1 and AF-2. To evaluate the involvement of AF-1 and AF-2 in the cardiovascular 
and uterine actions of E2, we generated mutant mice by electively targeting ERα 
A/B domain which contains AF-1 (AF-1 mice) or AF-2 in the ligand binding domain 
(AF-2 mice). We demonstrate that: i) both AF-1 and AF-2 are dispensable for E2 
accelerative action on endothelial healing; ii) AF-2 is required, whereas AF-1 is 
dispensable the atheroprotective effect of E2; iii) in the uterus of wild type mice, acute 
E2 or tamoxifen (a selective activator of AF-1) similarly regulate the expression of 
40 E2-inducible genes as well as epithelial cell proliferation; iv) These effects were 
abrogated in AF-1 and AF-2 mice; v) Chronic (4 weeks) treatment with E2 led to 
uterine hypertrophy and sustained luminal epithelial cell proliferation in wild type 
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Non-muscle myosin light chain kinase alters the release, the phenotype and 
the infl ammatory messages carried by circulating microparticles in mice
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Infl ammation is a physiological process consisting on cellular changes and infi ltration, 
and mediator release in response to an injury or abnormal stimulation. Infl ammation is 
orchestrated by interactions between infl ammatory and target cells, which upon activation 
and/or apoptosis can release microparticles (MPs).MPs, small membrane vesicles, may 
act as vectors for transfer of biological information. The aim of this study was to analyze 
the consequence of the deletion of non muscle myosin light chain kinase (nmMLCK) 
in MPs phenotype and their effects on target cells involved in infl ammation. nmMLCK 
is a protein that modulate infl ammatory response by affecting endothelial permeability 
and infl ammatory cell transmigration. Thus, circulating MPs from wild type (WT) and 
knock-out (KO) mice and their in vitro and ex vivo effects were studied. Circulating 
levels of MPs were higher in KO mice. Size of MPs from KO mice was higher than 
those of WT mice. Also, MPs from KO mice were less negatively charged. KO mice 
displayed a decreased number of circulating leukocyte-derived MPs which was 
associated with lower leukocyte count. In contrast, both platelet number and circulating 
levels of procoagulant MPs were increased in KO mice, indicating a probable activation 
of platelets. The analysis of secretome from endothelial cells treated with MPs from WT 
mice revealed an increase in IL6, LIX, KC, MCP1, MIP1γ, MIP2 cytokine secretion. MPs 
from KO mice induced the secretion of MCP1, MIP1γ, and MIP2. Endothelium-dependent 
relaxation of aorta was reduced when mice were injected with MPs from WT but not 
those from KO mice. Finally, injection of MPs from KO mice increased peritoneal 
pro-infl ammatory macrophages. These results suggest the involvement of nmMLCK 
in MP release and the deletion of nmMLCK affect the message carried by the MPs 
with respect to infl ammation in endothelial cells and macrophages. They underscore 
nmMLCK as a probable candidate in the control of infl ammatory response via MPs.
compare to those with stable plaques (16 [0-234] and 55 [36-157], p<0.001 and p<0.01 
respectively). The increase in LMP levels was also signifi cant when considering only 
the group of asymptomatic patients with unstable plaques (n=10, CD11b66b+MP/μl 
199 [153-410] and CD15+MP/μl 78 [56-258]) compared to those with stable plaques 
(n=14, 20 [0-251] and 55 [34-102], p<0.05). After logistic regression the neurologic 
symptoms (OR 48.7 95% CI 3.0-788, p<0.01) and the level of CD11b66b MP (OR 
24.2 95% CI 2.4-245, p<0.01) independently predict unstable plaques. 
Conclusions: LMP constitue a promising biomarker predicting plaque vulnerability 
in patients with high grade carotid stenosis. These data provide clues for identifying 
asymptomatic patients that are most at risk of neurologic events.
